Privacy-preserving model co-training in medical research is often hindered by server-dependent architectures incompatible with protected hospital data systems and by the predominant focus on relative effect measures (hazard ratios) which lack clinical interpretability for absolute survival risk assessment. We propose FedRD, a communication-efficient framework for federated risk difference estimation in distributed survival data. Unlike typical federated learning frameworks (e.g., FedAvg) that require persistent server connections and extensive iterative communication, FedRD is server-independent with minimal communication: one round of summary statistics exchange for the stratified model and three rounds for the unstratified model. Crucially, FedRD provides valid confidence intervals and hypothesis testing--capabilities absent in FedAvg-based frameworks. We provide theoretical guarantees by establishing the asymptotic properties of FedRD and prove that FedRD (unstratified) is asymptotically equivalent to pooled individual-level analysis. Simulation studies and real-world clinical applications across different countries demonstrate that FedRD outperforms local and federated baselines in both estimation accuracy and prediction performance, providing an architecturally feasible solution for absolute risk assessment in privacy-restricted, multi-site clinical studies.

Prognostic models in survival analysis are aimed at understanding the relationship between patients' covariates and the distribution of survival time. Traditionally, semi-parametric models, such as the Cox model, have been assumed. These often rely on strong proportionality assumptions of the hazard that might be violated in practice. Moreover, they do not often include covariate information updated over time. We propose a new flexible method for survival prediction: DeepHazard, a neural network for time-varying risks. Our approach is tailored for a wide range of continuous hazards forms, with the only restriction of being additive in time. A flexible implementation, allowing different optimization methods, along with any norm penalty, is developed. Numerical examples illustrate that our approach outperforms existing state-of-the-art methodology in terms of predictive capability evaluated through the C-index metric. The same is revealed on the popular real datasets as METABRIC, GBSG, and ACTG.

Estimating causal effects for survival outcomes in the high-dimensional setting is an extremely important topic for many biomedical applications as well as areas of social sciences. We propose a new orthogonal score method for treatment effect estimation and inference that results in asymptotically valid confidence intervals assuming only good estimation properties of the hazard outcome model and the conditional probability of treatment. This guarantee allows us to provide valid inference for the conditional treatment effect under the high-dimensional additive hazards model under considerably more generality than existing approaches. In addition, we develop a new Hazards Difference (HDi), estimator. We showcase that our approach has double-robustness properties in high dimensions: with cross-fitting, the HDi estimate is consistent under a wide variety of treatment assignment models; the HDi estimate is also consistent when the hazards model is misspecified and instead the true data generating mechanism follows a partially linear additive hazards model. We further develop a novel sparsity doubly robust result, where either the outcome or the treatment model can be a fully dense high-dimensional model. We apply our methods to study the treatment effect of radical prostatectomy versus conservative management for prostate cancer patients using the SEER-Medicare Linked Data.